Literature DB >> 24732796

A conserved loop in the catalytic domain of eukaryotic elongation factor 2 kinase plays a key role in its substrate specificity.

Claire E Moore1, Sergio Regufe da Mota1, Halina Mikolajek1, Christopher G Proud2.   

Abstract

Eukaryotic elongation factor 2 kinase (eEF2K) is the best-characterized member of the α-kinase family. Within this group, only eEF2K and myosin heavy chain kinases (MHCKs) have known substrates. Here we have studied the roles of specific residues, selected on the basis of structural data for MHCK A and TRPM7, in the function of eEF2K. Our data provide the first information regarding the basis of the substrate specificity of α-kinases, in particular the roles of residues in the so-called N/D loop, which appears to occupy a position in the structure of α-kinases similar to that of the activation loop in other kinases. Several mutations in the EEF2K gene occur in tumors, one of which (Arg303Cys) is at a highly conserved residue in the N/D loop. This mutation greatly enhances eEF2K activity and may be cytoprotective. Our data support the concept that the major autophosphorylation site (Thr348 in eEF2K) docks into a binding pocket to help create the kinase-competent conformation. This is similar to the situation for MHCK A and is consistent with this being a common feature of α-kinases.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24732796      PMCID: PMC4054288          DOI: 10.1128/MCB.00388-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

1.  Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress.

Authors:  Flore Kruiswijk; Laurensia Yuniati; Roberto Magliozzi; Teck Yew Low; Ratna Lim; Renske Bolder; Shabaz Mohammed; Christopher G Proud; Albert J R Heck; Michele Pagano; Daniele Guardavaccaro
Journal:  Sci Signal       Date:  2012-06-05       Impact factor: 8.192

2.  Tools for comparative protein structure modeling and analysis.

Authors:  Narayanan Eswar; Bino John; Nebojsa Mirkovic; Andras Fiser; Valentin A Ilyin; Ursula Pieper; Ashley C Stuart; Marc A Marti-Renom; M S Madhusudhan; Bozidar Yerkovich; Andrej Sali
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

3.  ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK.

Authors:  C A Hall-Jackson; D A Cross; N Morrice; C Smythe
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 5.  Signalling to translation: how signal transduction pathways control the protein synthetic machinery.

Authors:  Christopher G Proud
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

6.  Channel function is dissociated from the intrinsic kinase activity and autophosphorylation of TRPM7/ChaK1.

Authors:  Masayuki Matsushita; J Ashot Kozak; Yoshio Shimizu; Derek T McLachlin; Hiroto Yamaguchi; Fan-Yan Wei; Kazuhito Tomizawa; Hideki Matsui; Brian T Chait; Michael D Cahalan; Angus C Nairn
Journal:  J Biol Chem       Date:  2005-03-21       Impact factor: 5.157

7.  Analysis of the domain structure of elongation factor-2 kinase by mutagenesis.

Authors:  T A Diggle; C K Seehra; S Hase; N T Redpath
Journal:  FEBS Lett       Date:  1999-08-27       Impact factor: 4.124

8.  Mapping the functional domains of elongation factor-2 kinase.

Authors:  K S Pavur; A N Petrov; A G Ryazanov
Journal:  Biochemistry       Date:  2000-10-10       Impact factor: 3.162

9.  Calcium/calmodulin stimulates the autophosphorylation of elongation factor 2 kinase on Thr-348 and Ser-500 to regulate its activity and calcium dependence.

Authors:  Clint D J Tavares; John P O'Brien; Olga Abramczyk; Ashwini K Devkota; Kevin S Shores; Scarlett B Ferguson; Tamer S Kaoud; Mangalika Warthaka; Kyle D Marshall; Karin M Keller; Yan Zhang; Jennifer S Brodbelt; Bulent Ozpolat; Kevin N Dalby
Journal:  Biochemistry       Date:  2012-03-06       Impact factor: 3.162

10.  Purification and phosphorylation of elongation factor-2 kinase from rabbit reticulocytes.

Authors:  N T Redpath; C G Proud
Journal:  Eur J Biochem       Date:  1993-03-01
View more
  11 in total

1.  Structural basis for the calmodulin-mediated activation of eukaryotic elongation factor 2 kinase.

Authors:  Andrea Piserchio; Eta A Isiorho; Kimberly Long; Amanda L Bohanon; Eric A Kumar; Nathan Will; David Jeruzalmi; Kevin N Dalby; Ranajeet Ghose
Journal:  Sci Adv       Date:  2022-07-06       Impact factor: 14.957

Review 2.  Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.

Authors:  Rui Liu; Christopher G Proud
Journal:  Acta Pharmacol Sin       Date:  2016-01-25       Impact factor: 6.150

3.  Characterization of the Catalytic and Nucleotide Binding Properties of the α-Kinase Domain of Dictyostelium Myosin-II Heavy Chain Kinase A.

Authors:  Yidai Yang; Qilu Ye; Zongchao Jia; Graham P Côté
Journal:  J Biol Chem       Date:  2015-08-10       Impact factor: 5.157

4.  Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia.

Authors:  Claire E J Moore; Halina Mikolajek; Sergio Regufe da Mota; Xuemin Wang; Justin W Kenney; Jörn M Werner; Christopher G Proud
Journal:  Mol Cell Biol       Date:  2015-03-09       Impact factor: 4.272

Review 5.  Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer.

Authors: 
Journal:  Cancers (Basel)       Date:  2017-11-27       Impact factor: 6.639

6.  Mass Spectrometric Analysis of TRPM6 and TRPM7 Phosphorylation Reveals Regulatory Mechanisms of the Channel-Kinases.

Authors:  Na Cai; Zhiyong Bai; Vikas Nanda; Loren W Runnels
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

7.  MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.

Authors:  Recep Bayraktar; Martin Pichler; Pinar Kanlikilicer; Cristina Ivan; Emine Bayraktar; Nermin Kahraman; Burcu Aslan; Serpil Oguztuzun; Mustafa Ulasli; Ahmet Arslan; George Calin; Gabriel Lopez-Berestein; Bulent Ozpolat
Journal:  Oncotarget       Date:  2017-02-14

8.  Coordination of changes in expression and phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in hypertrophied cardiomyocytes.

Authors:  Satoshi Kameshima; Muneyoshi Okada; Shiro Ikeda; Yuki Watanabe; Hideyuki Yamawaki
Journal:  Biochem Biophys Rep       Date:  2016-06-28

Review 9.  Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target.

Authors:  Didem Karakas; Bulent Ozpolat
Journal:  J Mol Med (Berl)       Date:  2020-05-07       Impact factor: 4.599

10.  Structure of the Dictyostelium Myosin-II Heavy Chain Kinase A (MHCK-A) α-kinase domain apoenzyme reveals a novel autoinhibited conformation.

Authors:  Qilu Ye; Yidai Yang; Laura van Staalduinen; Scott William Crawley; Linda Liu; Stephanie Brennan; Graham P Côté; Zongchao Jia
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.